Comments Off on Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]
Comments Off on Alunbrig Gets FDA Approval for Frontline ALK-Positive Lung Cancer Patients
FDA has approved Alunbrig or Brigatinib for first-line treatment of patients with ALK-positive metastatic non-small cell lung cancer, as detected by [...]
Comments Off on FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]
Comments Off on Tackling Coronavirus during Lung Cancer Treatment
At the end of year 2019, a novel coronavirus was identified in Wuhan, a city in the Hubei Province of China. It spread rapidly and resulted in an increasing [...]
Comments Off on Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. [...]
Comments Off on Obesity May Boost Effectiveness of Lung Cancer Treatment, According to Study
The latest study in the field of lung cancer has revealed that an immune system-based treatment for lung cancer, worked better in people who were overweight in [...]
Comments Off on Lung Cancer Screenings Could Detect Signs of Heart Disease via Artificial Intelligence
According to a study presented at the annual meeting of the Radiological Society of North America, artificial intelligence could measure a common marker of [...]
Comments Off on Artificial Intelligence to Determine Who Will Benefit from Immunotherapy
Scientists can now determine which lung cancer patients will benefit from the expensive immunotherapy. They have previously used AI to determine the type of [...]
Comments Off on Nintedanib for Treatment of Advanced Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. [...]
Comments Off on Lung Cancer Awareness Month: Latest Researches in Lung Cancer Treatment
Lung Cancer Awareness Month is observed every year in the month of November. It intends to educate public about signs and symptoms of lung cancer. Creating [...]
Comments Off on Non-Toxic Nanoscale Treatment Promises Efficient Lung Cancer Treatment
Lung Cancer is one of the most deadly diseases all around the world. No country has been escaped from it. Scientists have been working towards finding new and [...]
Comments Off on New Lung Cancer Treatment Approved By NHS Scotland
The Scottish Medicines Consortium (SMC) confirms another immunotherapy treatment in combination with chemotherapy drugs is to be made available on NHS for [...]